BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy3070
(94 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 137 bits (345), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 42 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNI 123
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 137 bits (345), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKXVNHKNI 85
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 137 bits (345), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 42 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNI 123
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 137 bits (344), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKXVNHKNI 85
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 137 bits (344), Expect = 2e-33, Method: Composition-based stats.
Identities = 64/89 (71%), Positives = 75/89 (84%), Gaps = 1/89 (1%)
Query: 4 IGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKK 63
+G+ SR S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKK
Sbjct: 3 LGSMSR-SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK 61
Query: 64 LSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
LSRPFQN THAKRAYRE LMK VNHKN+
Sbjct: 62 LSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based
Assessment Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based
Assessment Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 136 bits (342), Expect = 3e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 5 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 65 QTHAKRAYRELVLMKCVNHKNI 86
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 136 bits (342), Expect = 3e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 136 bits (342), Expect = 3e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 3 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 62
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 63 QTHAKRAYRELVLMKCVNHKNI 84
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 136 bits (342), Expect = 4e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 135 bits (341), Expect = 4e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 5 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 65 QTHAKRAYRELVLMKCVNHKNI 86
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 135 bits (341), Expect = 5e-33, Method: Composition-based stats.
Identities = 64/88 (72%), Positives = 74/88 (84%), Gaps = 1/88 (1%)
Query: 5 GASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL 64
G+ SR S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKL
Sbjct: 1 GSMSR-SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL 59
Query: 65 SRPFQNVTHAKRAYREFKLMKLVNHKNV 92
SRPFQN THAKRAYRE LMK VNHKN+
Sbjct: 60 SRPFQNQTHAKRAYRELVLMKCVNHKNI 87
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 135 bits (340), Expect = 5e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor,
Sr-3737
Length = 364
Score = 135 bits (340), Expect = 6e-33, Method: Composition-based stats.
Identities = 62/82 (75%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKXVNHKNI 85
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 135 bits (339), Expect = 8e-33, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 135 bits (339), Expect = 8e-33, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 135 bits (339), Expect = 8e-33, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 5 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 64
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 65 QTHAKRAYRELVLMKCVNHKNI 86
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 134 bits (338), Expect = 9e-33, Method: Composition-based stats.
Identities = 60/76 (78%), Positives = 68/76 (89%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN THAKR
Sbjct: 4 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
AYRE LMK VNHKN+
Sbjct: 64 AYRELVLMKCVNHKNI 79
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 134 bits (338), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 134 bits (338), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (338), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 71/82 (86%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK+VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKVVNHKNI 85
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (338), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (337), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 71/82 (86%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK+VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKVVNHKNI 85
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 134 bits (337), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/79 (77%), Positives = 68/79 (86%)
Query: 14 STMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTH 73
+ F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN TH
Sbjct: 1 ANQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 60
Query: 74 AKRAYREFKLMKLVNHKNV 92
AKRAYRE LMK VNHKN+
Sbjct: 61 AKRAYRELVLMKCVNHKNI 79
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 134 bits (337), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/76 (80%), Positives = 67/76 (88%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN THAKR
Sbjct: 4 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
AYRE LMK VNHKN+
Sbjct: 64 AYRELVLMKCVNHKNI 79
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (337), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (336), Expect = 1e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 71/82 (86%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK+VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKVVNHKNI 85
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 134 bits (336), Expect = 2e-32, Method: Composition-based stats.
Identities = 61/76 (80%), Positives = 67/76 (88%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN THAKR
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 77 AYREFKLMKLVNHKNV 92
AYRE LMK VNHKN+
Sbjct: 63 AYRELVLMKCVNHKNI 78
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In
Map Kinase Jnk1
Length = 370
Score = 134 bits (336), Expect = 2e-32, Method: Composition-based stats.
Identities = 61/82 (74%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIVCAAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNI 85
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted
Quinoline Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted
Quinoline Inhibitor
Length = 356
Score = 133 bits (334), Expect = 3e-32, Method: Composition-based stats.
Identities = 61/76 (80%), Positives = 67/76 (88%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F++VEVGD+ FT+LKRYQNLKPIGSGAQGIVCAAYD +NVAIKKLSRPFQN THAKR
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 77 AYREFKLMKLVNHKNV 92
AYRE LMK VNHKN+
Sbjct: 63 AYRELVLMKCVNHKNI 78
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In
Map Kinase Jnk1
Length = 370
Score = 130 bits (326), Expect = 2e-31, Method: Composition-based stats.
Identities = 60/82 (73%), Positives = 70/82 (85%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S+ F++VE+GD+ FT+LKRYQNLKPIGSGAQGIV AAYD ++NVAIKKLSRPFQN
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE LMK+VNHKN+
Sbjct: 64 QTHAKRAYRELVLMKVVNHKNI 85
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 129 bits (325), Expect = 3e-31, Method: Composition-based stats.
Identities = 58/82 (70%), Positives = 68/82 (82%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S++ F++VEV D+ FT+LKRYQ LKPIGSGAQGIVCAA+DT NVA+KKLSRPFQN
Sbjct: 4 SKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 63
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE L+K VNHKN+
Sbjct: 64 QTHAKRAYRELVLLKCVNHKNI 85
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 127 bits (320), Expect = 1e-30, Method: Composition-based stats.
Identities = 57/82 (69%), Positives = 68/82 (82%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
S + + F++V+V D+ FT+LKRYQ LKPIGSGAQGIVCAA+DT NVA+KKLSRPFQN
Sbjct: 2 SHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 61
Query: 71 VTHAKRAYREFKLMKLVNHKNV 92
THAKRAYRE L+K VNHKN+
Sbjct: 62 QTHAKRAYRELVLLKCVNHKNI 83
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 102 bits (255), Expect = 4e-23, Method: Composition-based stats.
Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 3 LIGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
L+ S MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+K
Sbjct: 14 LVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 73
Query: 63 KLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
KLSRPFQ++ HAKR YRE +L+K + H+NV
Sbjct: 74 KLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 102 bits (255), Expect = 4e-23, Method: Composition-based stats.
Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 3 LIGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
L+ S MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+K
Sbjct: 14 LVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 73
Query: 63 KLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
KLSRPFQ++ HAKR YRE +L+K + H+NV
Sbjct: 74 KLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 102 bits (255), Expect = 4e-23, Method: Composition-based stats.
Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 3 LIGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
L+ S MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+K
Sbjct: 13 LVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 72
Query: 63 KLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
KLSRPFQ++ HAKR YRE +L+K + H+NV
Sbjct: 73 KLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 102 bits (253), Expect = 7e-23, Method: Composition-based stats.
Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 3 LIGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
L+ S MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+K
Sbjct: 13 LVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 72
Query: 63 KLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
KLSRPFQ++ HAKR YRE +L+K + H+NV
Sbjct: 73 KLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 102 bits (253), Expect = 7e-23, Method: Composition-based stats.
Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 3 LIGASSRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
L+ S MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+K
Sbjct: 14 LVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 73
Query: 63 KLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
KLSRPFQ++ HAKR YRE +L+K + H+NV
Sbjct: 74 KLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 100 bits (249), Expect = 2e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 100 bits (249), Expect = 2e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 100 bits (249), Expect = 2e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog
In Complex With P38 Map Kinase
Length = 360
Score = 100 bits (248), Expect = 2e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 99.8 bits (247), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 3 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 63 SIIHAKRTYRELRLLKHMKHENV 85
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha
Map Kinase
Length = 360
Score = 99.8 bits (247), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants
In Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 3 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 63 SIIHAKRTYRELRLLKHMKHENV 85
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 24 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 83
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 84 SIIHAKRTYRELRLLKHMKHENV 106
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 99.4 bits (246), Expect = 4e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A
Selective Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen
Activated Protein Kinase P38 (P38 Map Kinase) The
Mammalian Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino- Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 7 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 67 SIIHAKRTYRELRLLKHMKHENV 89
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 13 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 73 SIIHAKRTYRELRLLKHMKHENV 95
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-
8h-Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl-
Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-
8h-Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 13 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 73 SIIHAKRTYRELRLLKHMKHENV 95
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of
A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP
KINASE COMPLEX IN Solution
Length = 359
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 6 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 66 SIIHAKRTYRELRLLKHMKHENV 88
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 12 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 72 SIIHAKRTYRELRLLKHMKHENV 94
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Biphenyl Amide Inhibitor
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants
In Response To Inhibitor Binding
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Mapk Docking Peptide
Length = 362
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 3 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 63 SIIHAKRTYRELRLLKHMKHENV 85
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 7 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 67 SIIHAKRTYRELRLLKHMKHENV 89
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 12 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 72 SIIHAKRTYRELRLLKHMKHENV 94
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Biphenyl Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 99.4 bits (246), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 99.0 bits (245), Expect = 5e-22, Method: Composition-based stats.
Identities = 45/83 (54%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ
Sbjct: 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 61 SIIHAKRTYRELRLLKHMKHENV 83
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With
1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 98.6 bits (244), Expect = 7e-22, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 4 FYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 64 TYRELRLLKHMKHENV 79
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 98.2 bits (243), Expect = 9e-22, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 64 TYRELRLLKHMKHENV 79
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 98.2 bits (243), Expect = 9e-22, Method: Composition-based stats.
Identities = 45/85 (52%), Positives = 60/85 (70%)
Query: 8 SRMSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRP 67
S S+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRP
Sbjct: 22 SNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 68 FQNVTHAKRAYREFKLMKLVNHKNV 92
FQ++ HAKR YRE +L+K + H+NV
Sbjct: 82 FQSIIHAKRTYRELRLLKHMKHENV 106
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 98.2 bits (243), Expect = 9e-22, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 64 TYRELRLLKHMKHENV 79
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 98.2 bits (243), Expect = 1e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 18 FYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 77
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 78 TYRELRLLKHMKHENV 93
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 97.8 bits (242), Expect = 1e-21, Method: Composition-based stats.
Identities = 44/76 (57%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL PIGSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 13 FYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 73 TYRELRLLKHMKHENV 88
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 97.8 bits (242), Expect = 1e-21, Method: Composition-based stats.
Identities = 44/83 (53%), Positives = 60/83 (72%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS+ F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLS+PFQ
Sbjct: 13 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ 72
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HAKR YRE +L+K + H+NV
Sbjct: 73 SIIHAKRTYRELRLLKHMKHENV 95
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 97.8 bits (242), Expect = 1e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 14 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 73
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 74 TYRELRLLKHMKHENV 89
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 97.8 bits (242), Expect = 1e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 5 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 64
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 65 TYRELRLLKHMKHENV 80
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 8 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 68 TYRELRLLKHMKHENV 83
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 13 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 73 TYRELRLLKHMKHENV 88
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 7 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 66
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 67 TYRELRLLKHMKHENV 82
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 5 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 64
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 65 TYRELRLLKHMKHENV 80
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 6 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 65
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 66 TYRELRLLKHMKHENV 81
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 64 TYRELRLLKHMKHENV 79
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 75 TYRELRLLKHMKHENV 90
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 13 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 73 TYRELRLLKHMKHENV 88
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three
Clinical P38alpha Inhibitors
Length = 362
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 10 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 69
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 70 TYRELRLLKHMKHENV 85
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole
Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex
With A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 8 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 68 TYRELRLLKHMKHENV 83
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 75 TYRELRLLKHMKHENV 90
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 97.4 bits (241), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 75 TYRELRLLKHMKHENV 90
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 97.1 bits (240), Expect = 2e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 75 TYRELRLLKHMKHENV 90
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole
Based Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine
Based Inhibitor
Length = 366
Score = 96.7 bits (239), Expect = 3e-21, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 57/76 (75%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQNL P+GSGA G VCAA+DT T VA+KKLSRPFQ++ HAKR
Sbjct: 14 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 73
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 74 TYRELRLLKHMKHENV 89
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 91.3 bits (225), Expect = 1e-19, Method: Composition-based stats.
Identities = 41/83 (49%), Positives = 58/83 (69%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS F+ E+ T + + +R Q L+P+GSGA G VC+AYD +Q VA+KKLSRPFQ
Sbjct: 7 MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQ 66
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HA+R YRE +L+K + H+NV
Sbjct: 67 SLIHARRTYRELRLLKHLKHENV 89
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 91.3 bits (225), Expect = 1e-19, Method: Composition-based stats.
Identities = 41/83 (49%), Positives = 58/83 (69%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQ 69
MS F+ E+ T + + +R Q L+P+GSGA G VC+AYD +Q VA+KKLSRPFQ
Sbjct: 7 MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQ 66
Query: 70 NVTHAKRAYREFKLMKLVNHKNV 92
++ HA+R YRE +L+K + H+NV
Sbjct: 67 SLIHARRTYRELRLLKHLKHENV 89
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 90.9 bits (224), Expect = 1e-19, Method: Composition-based stats.
Identities = 39/76 (51%), Positives = 56/76 (73%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +R Q L+P+GSGA G VC+AYD +Q VA+KKLSRPFQ++ HA+R
Sbjct: 6 FYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARR 65
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 66 TYRELRLLKHLKHENV 81
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 89.7 bits (221), Expect = 3e-19, Method: Composition-based stats.
Identities = 38/76 (50%), Positives = 55/76 (72%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ E+ T + + +RYQ L P+GSGA G VC++YD + +A+KKLSRPFQ++ HAKR
Sbjct: 37 FYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR 96
Query: 77 AYREFKLMKLVNHKNV 92
YRE +L+K + H+NV
Sbjct: 97 TYRELRLLKHMKHENV 112
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 81.6 bits (200), Expect = 1e-16, Method: Composition-based stats.
Identities = 39/76 (51%), Positives = 52/76 (68%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ EV T + + Y++L+P+GSGA G VC+A D T VAIKKL RPFQ+ AKR
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 77 AYREFKLMKLVNHKNV 92
AYRE +L+K + H+NV
Sbjct: 71 AYRELRLLKHMRHENV 86
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 73.2 bits (178), Expect = 4e-14, Method: Composition-based stats.
Identities = 37/76 (48%), Positives = 50/76 (65%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ +V T + + K Y + +GSGA G VC+A D + + VAIKKLSRPFQ+ AKR
Sbjct: 28 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR 87
Query: 77 AYREFKLMKLVNHKNV 92
AYRE L+K + H+NV
Sbjct: 88 AYRELLLLKHMQHENV 103
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 73.2 bits (178), Expect = 4e-14, Method: Composition-based stats.
Identities = 37/76 (48%), Positives = 50/76 (65%)
Query: 17 FHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKR 76
F+ +V T + + K Y + +GSGA G VC+A D + + VAIKKLSRPFQ+ AKR
Sbjct: 10 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR 69
Query: 77 AYREFKLMKLVNHKNV 92
AYRE L+K + H+NV
Sbjct: 70 AYRELLLLKHMQHENV 85
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 64.3 bits (155), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 21 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLA 79
Query: 87 VNHKNV 92
H+N+
Sbjct: 80 FRHENI 85
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 64.3 bits (155), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 27 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 85
Query: 87 VNHKNV 92
H+N+
Sbjct: 86 FRHENI 91
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 64.3 bits (155), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 19 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 77
Query: 87 VNHKNV 92
H+N+
Sbjct: 78 FRHENI 83
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 64.3 bits (155), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 21 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLA 79
Query: 87 VNHKNV 92
H+N+
Sbjct: 80 FRHENI 85
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 63.9 bits (154), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 19 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 77
Query: 87 VNHKNV 92
H+N+
Sbjct: 78 FRHENI 83
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 63.9 bits (154), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 21 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 79
Query: 87 VNHKNV 92
H+N+
Sbjct: 80 FRHENI 85
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 63.9 bits (154), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 39 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 97
Query: 87 VNHKNV 92
H+N+
Sbjct: 98 FRHENI 103
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 63.9 bits (154), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 19 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 77
Query: 87 VNHKNV 92
H+N+
Sbjct: 78 FRHENI 83
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 63.9 bits (154), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 19 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 77
Query: 87 VNHKNV 92
H+N+
Sbjct: 78 FRHENI 83
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 63.5 bits (153), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 63.5 bits (153), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 19 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 77
Query: 87 VNHKNV 92
H+N+
Sbjct: 78 FRHENI 83
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 63.5 bits (153), Expect = 2e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 39 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 97
Query: 87 VNHKNV 92
H+N+
Sbjct: 98 FRHENI 103
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 24 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 82
Query: 87 VNHKNV 92
H+N+
Sbjct: 83 FRHENI 88
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 17 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 75
Query: 87 VNHKNV 92
H+N+
Sbjct: 76 FRHENI 81
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2
In Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 25 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 83
Query: 87 VNHKNV 92
H+N+
Sbjct: 84 FRHENI 89
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 16 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 74
Query: 87 VNHKNV 92
H+N+
Sbjct: 75 FRHENI 80
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide
Derived From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide
Derived From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 24 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 82
Query: 87 VNHKNV 92
H+N+
Sbjct: 83 FRHENI 88
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 17 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 75
Query: 87 VNHKNV 92
H+N+
Sbjct: 76 FRHENI 81
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 63.5 bits (153), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 63.2 bits (152), Expect = 3e-11, Method: Composition-based stats.
Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAIKK+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 62.8 bits (151), Expect = 5e-11, Method: Composition-based stats.
Identities = 29/66 (43%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY NL IG GA G+VC+AYD + VAI+K+S PF++ T+ +R RE K++
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLREIKILLR 81
Query: 87 VNHKNV 92
H+N+
Sbjct: 82 FRHENI 87
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 58.9 bits (141), Expect = 7e-10, Method: Composition-based stats.
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 24 DTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKL 83
D F + Y+ ++ IG+GA G+V +A T Q VAIKK+ F VT+AKR RE K+
Sbjct: 48 DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 84 MKLVNHKNV 92
+K H N+
Sbjct: 108 LKHFKHDNI 116
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 58.5 bits (140), Expect = 1e-09, Method: Composition-based stats.
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 24 DTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKL 83
D F + Y+ ++ IG+GA G+V +A T Q VAIKK+ F VT+AKR RE K+
Sbjct: 47 DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 84 MKLVNHKNV 92
+K H N+
Sbjct: 107 LKHFKHDNI 115
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 57.0 bits (136), Expect = 3e-09, Method: Composition-based stats.
Identities = 28/66 (42%), Positives = 42/66 (63%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F + RY L+ IG GA G+V +AYD + VAIKK+S PF++ T+ +R RE +++
Sbjct: 39 FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLREIQILLR 97
Query: 87 VNHKNV 92
H+NV
Sbjct: 98 FRHENV 103
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 53.5 bits (127), Expect = 3e-08, Method: Composition-based stats.
Identities = 26/65 (40%), Positives = 43/65 (66%), Gaps = 1/65 (1%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLV 87
+L++Y+ +K +G GA GIV + D T + VA+KK+ FQN T A+R +RE ++ +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 88 NHKNV 92
H+N+
Sbjct: 67 GHENI 71
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 52.0 bits (123), Expect = 8e-08, Method: Composition-based stats.
Identities = 26/68 (38%), Positives = 41/68 (60%)
Query: 25 TKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM 84
+ + I RY+ IG+G+ G VC AYD ++ VAIKK+ R F+++ KR RE ++
Sbjct: 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106
Query: 85 KLVNHKNV 92
+NH +V
Sbjct: 107 NRLNHDHV 114
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 50.4 bits (119), Expect = 3e-07, Method: Composition-based stats.
Identities = 28/68 (41%), Positives = 42/68 (61%), Gaps = 6/68 (8%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKK--LSRPFQNVTHAKRAYREFKLM 84
F + RY +LKP+G G G+V +A D + VAIKK L+ P Q+V H A RE K++
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKH---ALREIKII 62
Query: 85 KLVNHKNV 92
+ ++H N+
Sbjct: 63 RRLDHDNI 70
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 46.2 bits (108), Expect = 4e-06, Method: Composition-based stats.
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
+ I +Q +G GA G+VC+A T + VAIKK+ PF A R RE K++K
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKH 65
Query: 87 VNHKNV 92
H+N+
Sbjct: 66 FKHENI 71
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 46.2 bits (108), Expect = 4e-06, Method: Composition-based stats.
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
+ I +Q +G GA G+VC+A T + VAIKK+ PF A R RE K++K
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKH 65
Query: 87 VNHKNV 92
H+N+
Sbjct: 66 FKHENI 71
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 46.2 bits (108), Expect = 4e-06, Method: Composition-based stats.
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 1/66 (1%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
+ I +Q +G GA G+VC+A T + VAIKK+ PF A R RE K++K
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKH 65
Query: 87 VNHKNV 92
H+N+
Sbjct: 66 FKHENI 71
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 45.8 bits (107), Expect = 6e-06, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 31/46 (67%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM 84
IG G+ G V AYD T++NVAIKK++R F+++ KR RE ++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITIL 79
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 42.7 bits (99), Expect = 4e-05, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 29/46 (63%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM 84
IG G+ G V AYD +NVAIKK++R F+++ KR RE ++
Sbjct: 36 IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITIL 81
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 42.7 bits (99), Expect = 5e-05, Method: Composition-based stats.
Identities = 23/66 (34%), Positives = 37/66 (56%)
Query: 27 FTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 86
F +++Y+NL +G G+ G+V + T + VAIKK + K A RE KL+K
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 87 VNHKNV 92
+ H+N+
Sbjct: 81 LRHENL 86
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 42.7 bits (99), Expect = 5e-05, Method: Composition-based stats.
Identities = 22/65 (33%), Positives = 34/65 (52%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
T + RY+ + +G G G V A DT T + VAIK++ + A RE L+K +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 88 NHKNV 92
H+N+
Sbjct: 91 QHRNI 95
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 40.8 bits (94), Expect = 2e-04, Method: Composition-based stats.
Identities = 22/60 (36%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VAIK + + N T ++ +RE ++MK++NH N+
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 40.8 bits (94), Expect = 2e-04, Method: Composition-based stats.
Identities = 22/60 (36%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VAIK + + N T ++ +RE ++MK++NH N+
Sbjct: 14 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 40.0 bits (92), Expect = 4e-04, Method: Composition-based stats.
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 4/53 (7%)
Query: 13 LSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS 65
L + V VGD K K+Y + IG GA G V A D AT Q VAI++++
Sbjct: 6 LEKLRSIVSVGDPK----KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The
Ruthenium Phthalimide Complex
Length = 297
Score = 39.7 bits (91), Expect = 4e-04, Method: Composition-based stats.
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 4/53 (7%)
Query: 13 LSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS 65
L + V VGD K K+Y + IG GA G V A D AT Q VAI++++
Sbjct: 6 LEKLRSIVSVGDPK----KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 39.7 bits (91), Expect = 4e-04, Method: Composition-based stats.
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 4/53 (7%)
Query: 13 LSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS 65
L + V VGD K K+Y + IG GA G V A D AT Q VAI++++
Sbjct: 6 LEKLRSIVSVGDPK----KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 39.7 bits (91), Expect = 4e-04, Method: Composition-based stats.
Identities = 20/64 (31%), Positives = 35/64 (54%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 88
++++Y+ + IG G+ G+V + T Q VAIKK + K A RE +++K +
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 89 HKNV 92
H N+
Sbjct: 61 HPNL 64
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In
Complex With Atp
Length = 306
Score = 39.7 bits (91), Expect = 4e-04, Method: Composition-based stats.
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 4/53 (7%)
Query: 13 LSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS 65
L + V VGD K K+Y + IG GA G V A D AT Q VAI++++
Sbjct: 7 LEKLRSIVSVGDPK----KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 55
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 39.7 bits (91), Expect = 4e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 3 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 90 KNV 92
N+
Sbjct: 63 PNI 65
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 4 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 90 KNV 92
N+
Sbjct: 64 PNI 66
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
Length = 299
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 9 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 90 KNV 92
N+
Sbjct: 69 PNI 71
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin
B
Length = 289
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 4 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 90 KNV 92
N+
Sbjct: 64 PNI 66
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 6 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 90 KNV 92
N+
Sbjct: 66 PNI 68
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 3 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 90 KNV 92
N+
Sbjct: 63 PNI 65
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 27/46 (58%), Gaps = 4/46 (8%)
Query: 20 VEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS 65
V VGD K K+Y + IG GA G V A D AT Q VAI++++
Sbjct: 14 VSVGDPK----KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 55
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 6 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 90 KNV 92
N+
Sbjct: 66 PNI 68
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 5 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 90 KNV 92
N+
Sbjct: 65 PNI 67
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 4 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 90 KNV 92
N+
Sbjct: 64 PNI 66
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 90 KNV 92
N+
Sbjct: 61 PNI 63
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 9 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 90 KNV 92
N+
Sbjct: 69 PNI 71
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 4 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 90 KNV 92
N+
Sbjct: 64 PNI 66
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 90 KNV 92
N+
Sbjct: 61 PNI 63
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 3 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 90 KNV 92
N+
Sbjct: 63 PNI 65
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 3 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 90 KNV 92
N+
Sbjct: 63 PNI 65
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr
160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active
Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 3 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 90 KNV 92
N+
Sbjct: 63 PNI 65
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Dph- 042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Din- 234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With
Din- 232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With
Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor
Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 90 KNV 92
N+
Sbjct: 61 PNI 63
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 22/63 (34%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+ +Y+ L IG G G V A T Q VA+KK+ + A RE K+++L+ H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 90 KNV 92
+NV
Sbjct: 77 ENV 79
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 22/63 (34%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+ +Y+ L IG G G V A T Q VA+KK+ + A RE K+++L+ H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 90 KNV 92
+NV
Sbjct: 77 ENV 79
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 90 KNV 92
N+
Sbjct: 61 PNI 63
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
Length = 319
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA+K + + N + ++ +RE ++MK++NH N+
Sbjct: 9 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human
P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 38.9 bits (89), Expect = 6e-04, Method: Composition-based stats.
Identities = 22/63 (34%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+ +Y+ L IG G G V A T Q VA+KK+ + A RE K+++L+ H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 90 KNV 92
+NV
Sbjct: 76 ENV 78
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 38.9 bits (89), Expect = 7e-04, Method: Composition-based stats.
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA+K + + N + ++ +RE ++MK++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 38.9 bits (89), Expect = 7e-04, Method: Composition-based stats.
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA+K + + N + ++ +RE ++MK++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 38.9 bits (89), Expect = 7e-04, Method: Composition-based stats.
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA+K + + N + ++ +RE ++MK++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint
And Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 38.9 bits (89), Expect = 7e-04, Method: Composition-based stats.
Identities = 22/63 (34%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+ +Y+ L IG G G V A T Q VA+KK+ + A RE K+++L+ H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 90 KNV 92
+NV
Sbjct: 77 ENV 79
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 38.5 bits (88), Expect = 0.001, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 90
+ +Q ++ IG G G+V A + T + VA+KK+ + A RE L+K +NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 91 NV 92
N+
Sbjct: 62 NI 63
>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium
Parvum In Complex With Indirubin E804
pdb|3EB0|C Chain C, Crystal Structure Of Cgd4_240 From Cryptosporidium
Parvum In Complex With Indirubin E804
Length = 383
Score = 38.5 bits (88), Expect = 0.001, Method: Composition-based stats.
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 6/62 (9%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 90
K+Y K +G+G+ GIVC +D + + A+KK+ + + RE +MK+++H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHV 60
Query: 91 NV 92
N+
Sbjct: 61 NI 62
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 38.5 bits (88), Expect = 0.001, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+++Y+ L+ IG G G V A + T + VA+K++ + A RE L+K + H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 90 KNV 92
KN+
Sbjct: 61 KNI 63
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 38.5 bits (88), Expect = 0.001, Method: Composition-based stats.
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+++Y+ L+ IG G G V A + T + VA+K++ + A RE L+K + H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 90 KNV 92
KN+
Sbjct: 61 KNI 63
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 38.1 bits (87), Expect = 0.001, Method: Composition-based stats.
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ K IG G V A T + VA+K + + N T ++ +RE ++MK++NH N+
Sbjct: 17 YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA++ + + N + ++ +RE ++MK++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 37.7 bits (86), Expect = 0.001, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 34/60 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA++ + + N + ++ +RE ++MK++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 37.4 bits (85), Expect = 0.002, Method: Composition-based stats.
Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLV 87
KRY+ L +G G V A D T Q VAIKK+ ++ + A RE KL++ +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 88 NHKNV 92
+H N+
Sbjct: 70 SHPNI 74
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 37.4 bits (85), Expect = 0.002, Method: Composition-based stats.
Identities = 19/63 (30%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+ K+ + A RE L+K +NH
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 90 KNV 92
N+
Sbjct: 62 PNI 64
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 37.4 bits (85), Expect = 0.002, Method: Composition-based stats.
Identities = 19/63 (30%), Positives = 33/63 (52%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ +Q ++ IG G G+V A + T + VA+ K+ + A RE L+K +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 90 KNV 92
N+
Sbjct: 61 PNI 63
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 37.0 bits (84), Expect = 0.003, Method: Composition-based stats.
Identities = 19/64 (29%), Positives = 37/64 (57%), Gaps = 1/64 (1%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 88
++++YQ L+ +G G G+V A D+ + VA+K++ ++ A RE L+K ++
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 89 HKNV 92
H N+
Sbjct: 78 HPNI 81
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 37.0 bits (84), Expect = 0.003, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 31/60 (51%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
YQ +K +GSGA G V D T AIK + + + + + E ++KL++H N+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 37.0 bits (84), Expect = 0.003, Method: Composition-based stats.
Identities = 19/64 (29%), Positives = 37/64 (57%), Gaps = 1/64 (1%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 88
++++YQ L+ +G G G+V A D+ + VA+K++ ++ A RE L+K ++
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 89 HKNV 92
H N+
Sbjct: 78 HPNI 81
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 36.6 bits (83), Expect = 0.004, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 33/60 (55%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ LK IG G V A T + VA+K + + N + ++ +RE ++ K++NH N+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 35.4 bits (80), Expect = 0.007, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHK 90
RY+ + +G G+ G V D T Q A+K +S R + T + RE +L+K ++H
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 91 NV 92
N+
Sbjct: 87 NI 88
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumpless Bki Analog
Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 35.4 bits (80), Expect = 0.008, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHK 90
RY+ + +G G+ G V D T Q A+K +S R + T + RE +L+K ++H
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 91 NV 92
N+
Sbjct: 87 NI 88
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 35.4 bits (80), Expect = 0.009, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHK 90
RY+ + +G G+ G V D T Q A+K +S R + T + RE +L+K ++H
Sbjct: 51 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 91 NV 92
N+
Sbjct: 111 NI 112
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 35.4 bits (80), Expect = 0.009, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHK 90
RY+ + +G G+ G V D T Q A+K +S R + T + RE +L+K ++H
Sbjct: 50 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 91 NV 92
N+
Sbjct: 110 NI 111
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 35.0 bits (79), Expect = 0.010, Method: Composition-based stats.
Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKN 91
YQ +K +G G+ G V AY T T Q VA+K +++ + + R RE ++L+ H +
Sbjct: 16 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 92 V 92
+
Sbjct: 76 I 76
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In
Presence Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In
Presence Of 3brb-Pp1
Length = 298
Score = 35.0 bits (79), Expect = 0.010, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHK 90
RY+ + +G G+ G V D T Q A+K +S R + T + RE +L+K ++H
Sbjct: 33 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 91 NV 92
N+
Sbjct: 93 NI 94
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 35.0 bits (79), Expect = 0.011, Method: Composition-based stats.
Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
+G G GIV A D + Q +AIK++ P ++ +++ + E L K + HKN+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNI 81
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of
Cryptosporidium Parvum Calcium Dependent Protein Kinase
In Complex With 3- Mb-Pp1
Length = 287
Score = 34.7 bits (78), Expect = 0.013, Method: Composition-based stats.
Identities = 19/65 (29%), Positives = 32/65 (49%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
T +RY + +G G+ G V D TQQ A+K +++ RE +L+K +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 88 NHKNV 92
+H N+
Sbjct: 79 DHPNI 83
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 34.7 bits (78), Expect = 0.013, Method: Composition-based stats.
Identities = 19/65 (29%), Positives = 32/65 (49%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
T +RY + +G G+ G V D TQQ A+K +++ RE +L+K +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 88 NHKNV 92
+H N+
Sbjct: 79 DHPNI 83
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 34.7 bits (78), Expect = 0.014, Method: Composition-based stats.
Identities = 19/65 (29%), Positives = 32/65 (49%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
T +RY + +G G+ G V D TQQ A+K +++ RE +L+K +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 88 NHKNV 92
+H N+
Sbjct: 79 DHPNI 83
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 34.7 bits (78), Expect = 0.015, Method: Composition-based stats.
Identities = 19/58 (32%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A + T + VA+KK+ + + + E +M+ +H NV
Sbjct: 49 NFIKIGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHDNV 104
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 34.3 bits (77), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
+G G GIV A D + Q +AIK++ P ++ +++ + E L K + HKN+
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNI 67
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 33.9 bits (76), Expect = 0.022, Method: Composition-based stats.
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 11/62 (17%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y N K IG+G+ G+V A + + VAIKK+ + F+N RE ++M++V H
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN--------RELQIMRIVKHP 92
Query: 91 NV 92
NV
Sbjct: 93 NV 94
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 33.5 bits (75), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKN 91
YQ +K +G G+ G V AY T T Q VA+K +++ + + R RE ++L+ H +
Sbjct: 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 92 V 92
+
Sbjct: 75 I 75
>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41
Length = 417
Score = 33.5 bits (75), Expect = 0.034, Method: Composition-based stats.
Identities = 20/49 (40%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYRE 80
RY+ LK IG G+ G V AYD Q+VA+K V + KR +R+
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM-------VRNEKRFHRQ 139
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain
Of The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 33.5 bits (75), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKN 91
YQ +K +G G+ G V AY T T Q VA+K +++ + + R RE ++L+ H +
Sbjct: 6 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 92 V 92
+
Sbjct: 66 I 66
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From
Yeast Snf1
Length = 274
Score = 33.1 bits (74), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKN 91
YQ +K +G G+ G V AY T T Q VA+K +++ + + R RE ++L+ H +
Sbjct: 10 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 92 V 92
+
Sbjct: 70 I 70
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 32.7 bits (73), Expect = 0.051, Method: Composition-based stats.
Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA-YREFKLMKLVNHK 90
RYQ +K +GSGA G V D T AIK + + T A E ++K ++H
Sbjct: 5 RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 91 NV 92
N+
Sbjct: 65 NI 66
>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex
With An Indirubin Ligand
Length = 429
Score = 32.3 bits (72), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 20/31 (64%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
RY+ LK IG G+ G V AYD Q+VA+K
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK 128
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 32.3 bits (72), Expect = 0.061, Method: Composition-based stats.
Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA-YREFKLMKLVNHK 90
RYQ +K +GSGA G V D T AIK + + T A E ++K ++H
Sbjct: 22 RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 91 NV 92
N+
Sbjct: 82 NI 83
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 32.3 bits (72), Expect = 0.065, Method: Composition-based stats.
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY+ +K IGSG G+ D + + VA+K + R + + KR +++NH++
Sbjct: 20 RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKR--------EIINHRS 71
Query: 92 VSH 94
+ H
Sbjct: 72 LRH 74
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 32.3 bits (72), Expect = 0.077, Method: Composition-based stats.
Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 23 GDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 82
G TK I + Y IG G+ G V A T+ A KK+ + F V R +E +
Sbjct: 18 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIE 75
Query: 83 LMKLVNHKNV 92
+MK ++H N+
Sbjct: 76 IMKSLDHPNI 85
>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|B Chain B, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|C Chain C, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|D Chain D, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANR|A Chain A, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|B Chain B, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|C Chain C, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|D Chain D, Human Dyrk1aHARMINE COMPLEX
Length = 368
Score = 32.0 bits (71), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 7/61 (11%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLV 87
+ RY+ IG G+ G V AYD Q+ VAIK K + F N +A E +L++L+
Sbjct: 34 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELM 88
Query: 88 N 88
N
Sbjct: 89 N 89
>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|B Chain B, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|C Chain C, Human Dyrk1a In Complex With Leucettine L41
Length = 382
Score = 32.0 bits (71), Expect = 0.082, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 7/61 (11%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLV 87
+ RY+ IG G+ G V AYD Q+ VAIK K + F N +A E +L++L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELM 107
Query: 88 N 88
N
Sbjct: 108 N 108
>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|B Chain B, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|C Chain C, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|D Chain D, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2WO6|A Chain A, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
pdb|2WO6|B Chain B, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
Length = 382
Score = 32.0 bits (71), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 7/61 (11%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLV 87
+ RY+ IG G+ G V AYD Q+ VAIK K + F N +A E +L++L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELM 107
Query: 88 N 88
N
Sbjct: 108 N 108
>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2)
Length = 429
Score = 32.0 bits (71), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 19/31 (61%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
RY+ LK IG G G V AYD Q+VA+K
Sbjct: 98 RYEVLKVIGKGXFGQVVKAYDHKVHQHVALK 128
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 32.0 bits (71), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 23 GDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 82
G TK I + Y IG G+ G V A T+ A KK+ + F V R +E +
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIE 58
Query: 83 LMKLVNHKNV 92
+MK ++H N+
Sbjct: 59 IMKSLDHPNI 68
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 31.6 bits (70), Expect = 0.11, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ + IGSGA +V AAY ++ VAIK+++ + T +E + M +H N+
Sbjct: 12 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNI 70
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 31.6 bits (70), Expect = 0.11, Method: Composition-based stats.
Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
Y+ + IGSGA +V AAY ++ VAIK+++ + T +E + M +H N+
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNI 75
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 24 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 79
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 31.2 bits (69), Expect = 0.15, Method: Composition-based stats.
Identities = 21/74 (28%), Positives = 37/74 (50%), Gaps = 3/74 (4%)
Query: 23 GDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPF---QNVTHAKRAYR 79
G + + K+Y IG G+ G+V A + T+ AIK +++ N +R
Sbjct: 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 80 EFKLMKLVNHKNVS 93
E +LMK ++H N++
Sbjct: 78 EVRLMKKLHHPNIA 91
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 31.2 bits (69), Expect = 0.15, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 33 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 88
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 31.2 bits (69), Expect = 0.15, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 35 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 90
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 31.2 bits (69), Expect = 0.15, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 28 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 83
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 31.2 bits (69), Expect = 0.17, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 31.2 bits (69), Expect = 0.17, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 133
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 31.2 bits (69), Expect = 0.17, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 31.2 bits (69), Expect = 0.17, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 30.8 bits (68), Expect = 0.18, Method: Composition-based stats.
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY+ +K IGSG G+ D + + VA+K + R + + KR +++NH++
Sbjct: 20 RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR--------EIINHRS 71
Query: 92 VSH 94
+ H
Sbjct: 72 LRH 74
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 30.8 bits (68), Expect = 0.19, Method: Composition-based stats.
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 35 NLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
N IG G+ GIVC A ++ + VA+KK+ + + + E +M+ H+NV
Sbjct: 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENV 210
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 30.8 bits (68), Expect = 0.19, Method: Composition-based stats.
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY+ +K IGSG G+ D + + VA+K + R + + KR +++NH++
Sbjct: 20 RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR--------EIINHRS 71
Query: 92 VSH 94
+ H
Sbjct: 72 LRH 74
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 30.8 bits (68), Expect = 0.19, Method: Composition-based stats.
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY+ +K IGSG G+ D + + VA+K + R + + KR +++NH++
Sbjct: 19 RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR--------EIINHRS 70
Query: 92 VSH 94
+ H
Sbjct: 71 LRH 73
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 30.8 bits (68), Expect = 0.21, Method: Composition-based stats.
Identities = 19/55 (34%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKNV 92
+G G+ G V A TQQ VA+K +SR + R RE +KL+ H ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 30.4 bits (67), Expect = 0.24, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 30.4 bits (67), Expect = 0.24, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 77
Query: 91 NV 92
N+
Sbjct: 78 NI 79
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 30.4 bits (67), Expect = 0.24, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 23 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 74
Query: 91 NV 92
N+
Sbjct: 75 NI 76
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 30.4 bits (67), Expect = 0.24, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 30.4 bits (67), Expect = 0.25, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 30.4 bits (67), Expect = 0.25, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 91 NV 92
N+
Sbjct: 74 NI 75
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 30.4 bits (67), Expect = 0.26, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 20/36 (55%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSR 66
++Y + P+GSGA G V A D + V +K + +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKK 59
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 30.4 bits (67), Expect = 0.27, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 35 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 86
Query: 91 NV 92
N+
Sbjct: 87 NI 88
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 30.4 bits (67), Expect = 0.28, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 41 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 92
Query: 91 NV 92
N+
Sbjct: 93 NI 94
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 30.4 bits (67), Expect = 0.28, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 30 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 81
Query: 91 NV 92
N+
Sbjct: 82 NI 83
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 30.4 bits (67), Expect = 0.28, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 91 NV 92
N+
Sbjct: 86 NI 87
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 30.4 bits (67), Expect = 0.28, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 91 NV 92
N+
Sbjct: 86 NI 87
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 30.4 bits (67), Expect = 0.28, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 78
Query: 91 NV 92
N+
Sbjct: 79 NI 80
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 111
Query: 91 NV 92
N+
Sbjct: 112 NI 113
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 30.0 bits (66), Expect = 0.32, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 101
Query: 91 NV 92
N+
Sbjct: 102 NI 103
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 30.0 bits (66), Expect = 0.32, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 109
Query: 91 NV 92
N+
Sbjct: 110 NI 111
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 30.0 bits (66), Expect = 0.32, Method: Composition-based stats.
Identities = 18/63 (28%), Positives = 32/63 (50%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY +K IGSG G+ D T++ VA+K + R + +R +++NH++
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR--------EIINHRS 72
Query: 92 VSH 94
+ H
Sbjct: 73 LRH 75
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 30.0 bits (66), Expect = 0.33, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 91 NV 92
N+
Sbjct: 108 NI 109
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 30.0 bits (66), Expect = 0.33, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 91 NV 92
N+
Sbjct: 108 NI 109
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 30.0 bits (66), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHK 90
Y + K IG+G+ G+V A + + VAIKK+ + F+N RE ++M+ ++H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 152
Query: 91 NV 92
N+
Sbjct: 153 NI 154
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 30.0 bits (66), Expect = 0.38, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+++Y L+ IG G G+V A + + A+KK+ ++ RE ++K + H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 90 KNV 92
N+
Sbjct: 60 SNI 62
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 30.0 bits (66), Expect = 0.38, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+++Y L+ IG G G+V A + + A+KK+ ++ RE ++K + H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 90 KNV 92
N+
Sbjct: 60 SNI 62
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 30.0 bits (66), Expect = 0.38, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
+++Y L+ IG G G+V A + + A+KK+ ++ RE ++K + H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 90 KNV 92
N+
Sbjct: 60 SNI 62
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 29.6 bits (65), Expect = 0.44, Method: Composition-based stats.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 1/62 (1%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNH 89
K + +L+ IG G+ G V A D + VAIKK+S Q+ + +E + ++ + H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 90 KN 91
N
Sbjct: 114 PN 115
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 29.6 bits (65), Expect = 0.45, Method: Composition-based stats.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 1/62 (1%)
Query: 31 KRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNH 89
K + +L+ IG G+ G V A D + VAIKK+S Q+ + +E + ++ + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 90 KN 91
N
Sbjct: 75 PN 76
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 29.6 bits (65), Expect = 0.49, Method: Composition-based stats.
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAIK +S+ + A+ A E +++K +NH
Sbjct: 15 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex
With Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex
With Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex
With Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 29.6 bits (65), Expect = 0.50, Method: Composition-based stats.
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAIK +S+ + A+ A E +++K +NH
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 29.6 bits (65), Expect = 0.50, Method: Composition-based stats.
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAIK +S+ + A+ A E +++K +NH
Sbjct: 22 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 29.6 bits (65), Expect = 0.50, Method: Composition-based stats.
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAIK +S+ + A+ A E +++K +NH
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 29.3 bits (64), Expect = 0.52, Method: Composition-based stats.
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAIK +S+ + A+ A E +++K +NH
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
>pdb|4DHZ|A Chain A, The Structure Of HCEOTUB1-Ubiquitin Aldehyde-Ubc13~ub
Length = 288
Score = 29.3 bits (64), Expect = 0.54, Method: Composition-based stats.
Identities = 13/36 (36%), Positives = 21/36 (58%), Gaps = 7/36 (19%)
Query: 34 QNLKPIGSGAQGIVCAAYDTA-------TQQNVAIK 62
Q +P+GS ++G+ C AYD A QQ +A++
Sbjct: 9 QKQEPLGSDSEGVNCLAYDEAIMAQQDRIQQEIAVQ 44
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.9 bits (63), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.9 bits (63), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 28.9 bits (63), Expect = 0.73, Method: Composition-based stats.
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 8/63 (12%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
RY+ +K IG+G G+ D + VA+K + R + + KR +++NH++
Sbjct: 20 RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKR--------EIINHRS 71
Query: 92 VSH 94
+ H
Sbjct: 72 LRH 74
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 28.9 bits (63), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 64
Query: 90 KNV 92
+NV
Sbjct: 65 ENV 67
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 28.9 bits (63), Expect = 0.81, Method: Composition-based stats.
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 91
+++ L+ +G+G V + T VA+K++ + T + A RE LMK + H+N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-AIREISLMKELKHEN 64
Query: 92 V 92
+
Sbjct: 65 I 65
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 28.5 bits (62), Expect = 0.94, Method: Composition-based stats.
Identities = 19/59 (32%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAI+ +S+ + A+ A E +++K +NH
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 28.5 bits (62), Expect = 0.94, Method: Composition-based stats.
Identities = 19/59 (32%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 37 KPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 89
K +GSGA G V A++ T + VAI+ +S+ + A+ A E +++K +NH
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 28.5 bits (62), Expect = 0.94, Method: Composition-based stats.
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 6/73 (8%)
Query: 20 VEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR 79
V+ GD + +L Y IG G+ GIVC A + + + VA+K + + + +
Sbjct: 38 VDQGDPRL-LLDSYVK---IGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFN 91
Query: 80 EFKLMKLVNHKNV 92
E +M+ H NV
Sbjct: 92 EVVIMRDYQHFNV 104
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 90 KNV 92
+NV
Sbjct: 65 ENV 67
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor
Binding Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor
Binding Site
Length = 271
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 28.1 bits (61), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 28.1 bits (61), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human
Chk1 Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human
Chk1 Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human
Chk1 Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human
Chk1 Kinase Domain
Length = 273
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 88
+L Y + +G+GA G+V + AT N A K + P ++ R +E + M ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLR 212
Query: 89 H 89
H
Sbjct: 213 H 213
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 90 KNV 92
+NV
Sbjct: 65 ENV 67
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 62
Query: 90 KNV 92
+NV
Sbjct: 63 ENV 65
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + K++NH
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 90 KNV 92
+NV
Sbjct: 64 ENV 66
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors:
Insights Into Hydrogen Bonding And Protein-Ligand
Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And
Selective Inhibition Of Chk1: Prediction And
Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And
Selective Inhibition Of Chk1: Prediction And
Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And
Selective Inhibition Of Chk1: Prediction And
Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 36 LKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
++ +G GA G V A + T++ VA+K + + V + +E + K++NH+NV
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 67
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle
Checkpoint Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In
Complex With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 36 LKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
++ +G GA G V A + T++ VA+K + + V + +E + K++NH+NV
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 67
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 36 LKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
++ +G GA G V A + T++ VA+K + + V + +E + K++NH+NV
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 67
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With
Inhibitor 38
Length = 322
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 36 LKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
++ +G GA G V A + T++ VA+K + + V + +E + K++NH+NV
Sbjct: 11 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 66
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As
Potent Chk1 Inhibitors
Length = 295
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 36 LKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNV 92
++ +G GA G V A + T++ VA+K + + V + +E + K++NH+NV
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 67
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 28.1 bits (61), Expect = 1.4, Method: Composition-based stats.
Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 88
+L Y + +G+GA G+V + AT N A K + P ++ R +E + M ++
Sbjct: 49 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLR 106
Query: 89 H 89
H
Sbjct: 107 H 107
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
L ++ ++ +G G G+V A + N AIK++ P + + K RE K + + H
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEH 63
Query: 90 KNV 92
+
Sbjct: 64 PGI 66
>pdb|1WVE|A Chain A, P-Cresol Methylhydroxylase: Alteration Of The Structure Of
The Flavoprotein Subunit Upon Its Binding To The
Cytochrome Subunit
pdb|1WVE|B Chain B, P-Cresol Methylhydroxylase: Alteration Of The Structure Of
The Flavoprotein Subunit Upon Its Binding To The
Cytochrome Subunit
pdb|1WVF|A Chain A, P-cresol Methylhydroxylase: Alteration Of The Structure Of
The Flavoprotein Subunit Upon Its Binding To The
Cytochrome Subunit
Length = 520
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
+ L+ +T E G T +++K+ Q K G GA + A Y T Q +V K ++ F+
Sbjct: 289 AHLTRAQYTTEPGHTPDSVIKQMQ--KDTGMGAWNLYAALYGTQEQVDVNWKIVTDVFKK 346
Query: 71 VTHAKRAYRE 80
+ + +E
Sbjct: 347 LGKGRIVTQE 356
>pdb|1DII|A Chain A, Crystal Structure Of P-Cresol Methylhydroxylase At 2.5 A
Resolution
pdb|1DII|B Chain B, Crystal Structure Of P-Cresol Methylhydroxylase At 2.5 A
Resolution
pdb|1DIQ|A Chain A, Crystal Structure Of P-Cresol Methylhydroxylase With
Substrate Bound
pdb|1DIQ|B Chain B, Crystal Structure Of P-Cresol Methylhydroxylase With
Substrate Bound
Length = 521
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 11 SRLSTMFHTVEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQN 70
+ L+ +T E G T +++K+ Q K G GA + A Y T Q +V K ++ F+
Sbjct: 290 AHLTRAQYTTEPGHTPDSVIKQMQ--KDTGMGAWNLYAALYGTQEQVDVNWKIVTDVFKK 347
Query: 71 VTHAKRAYRE 80
+ + +E
Sbjct: 348 LGKGRIVTQE 357
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
L ++ ++ +G G G+V A + N AIK++ P + + K RE K + + H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEH 62
Query: 90 KNV 92
+
Sbjct: 63 PGI 65
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 20/65 (30%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 29 ILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHA-KRAYREFKLMKLV 87
I +RY+ + +G G V A DT VAIK + P + KR RE +
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 88 NHKNV 92
+H+N+
Sbjct: 69 SHQNI 73
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---N 88
RY+ + IG GA G V A D + VA+K + P RE L++ +
Sbjct: 5 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 89 HKNV 92
H NV
Sbjct: 65 HPNV 68
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---N 88
RY+ + IG GA G V A D + VA+K + P RE L++ +
Sbjct: 5 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 89 HKNV 92
H NV
Sbjct: 65 HPNV 68
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---N 88
RY+ + IG GA G V A D + VA+K + P RE L++ +
Sbjct: 5 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 89 HKNV 92
H NV
Sbjct: 65 HPNV 68
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 27.3 bits (59), Expect = 2.3, Method: Composition-based stats.
Identities = 22/66 (33%), Positives = 29/66 (43%), Gaps = 16/66 (24%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHA------------KRAYREFKLMKL 86
I SG+ G VCA D+ VAIK R F V+ KR RE +L+
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIK---RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 87 VNHKNV 92
+H N+
Sbjct: 86 FHHPNI 91
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex
With Sb203580
Length = 362
Score = 27.3 bits (59), Expect = 2.3, Method: Composition-based stats.
Identities = 22/66 (33%), Positives = 29/66 (43%), Gaps = 16/66 (24%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHA------------KRAYREFKLMKL 86
I SG+ G VCA D+ VAIK R F V+ KR RE +L+
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIK---RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 87 VNHKNV 92
+H N+
Sbjct: 86 FHHPNI 91
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 26.9 bits (58), Expect = 2.7, Method: Composition-based stats.
Identities = 15/65 (23%), Positives = 30/65 (46%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
++ YQ + +G GA +V T Q A K ++ + ++ RE ++ +L+
Sbjct: 1 SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 88 NHKNV 92
H N+
Sbjct: 61 KHPNI 65
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 26.9 bits (58), Expect = 2.9, Method: Composition-based stats.
Identities = 15/65 (23%), Positives = 30/65 (46%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
++ YQ + +G GA +V T Q A K ++ + ++ RE ++ +L+
Sbjct: 1 SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 88 NHKNV 92
H N+
Sbjct: 61 KHPNI 65
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 26.9 bits (58), Expect = 2.9, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 19/36 (52%)
Query: 32 RYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRP 67
RY+ + IG GA G V A D + VA+K + P
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP 45
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 16/73 (21%), Positives = 31/73 (42%)
Query: 20 VEVGDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR 79
V++G YQ + +G GA +V Q A K ++ + ++ R
Sbjct: 11 VDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER 70
Query: 80 EFKLMKLVNHKNV 92
E ++ +L+ H N+
Sbjct: 71 EARICRLLKHPNI 83
>pdb|2XSR|A Chain A, Crystal Structure Of Wild Type Acinetobacter
Radioresistens Catechol 1,2 Dioxygenase
Length = 312
Score = 26.6 bits (57), Expect = 3.4, Method: Composition-based stats.
Identities = 9/28 (32%), Positives = 18/28 (64%)
Query: 45 GIVCAAYDTATQQNVAIKKLSRPFQNVT 72
G+V A D + +A ++L +PF+++T
Sbjct: 261 GLVATATDVTDEAEIARRELDKPFKHIT 288
>pdb|2XSV|A Chain A, Crystal Structure Of Wild Type Acinetobacter
Radioresistens Catechol 1,2 Dioxygenase
Length = 312
Score = 26.6 bits (57), Expect = 3.4, Method: Composition-based stats.
Identities = 9/28 (32%), Positives = 18/28 (64%)
Query: 45 GIVCAAYDTATQQNVAIKKLSRPFQNVT 72
G+V A D + +A ++L +PF+++T
Sbjct: 261 GLVATATDVTDEAEIARRELDKPFKHIT 288
>pdb|2XSU|A Chain A, Crystal Structure Of The A72g Mutant Of Acinetobacter
Radioresistens Catechol 1,2 Dioxygenase
Length = 312
Score = 26.6 bits (57), Expect = 3.4, Method: Composition-based stats.
Identities = 9/28 (32%), Positives = 18/28 (64%)
Query: 45 GIVCAAYDTATQQNVAIKKLSRPFQNVT 72
G+V A D + +A ++L +PF+++T
Sbjct: 261 GLVATATDVTDEAEIARRELDKPFKHIT 288
>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|B Chain B, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|C Chain C, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|D Chain D, Crystal Structure Of Apo Human Ck1d
pdb|3UYT|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|C Chain C, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|D Chain D, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UZP|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|3UZP|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|4HNF|A Chain A, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HNF|B Chain B, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HGT|A Chain A, Crystal Structure Of Ck1d With Compound 13
pdb|4HGT|B Chain B, Crystal Structure Of Ck1d With Compound 13
Length = 296
Score = 26.2 bits (56), Expect = 4.7, Method: Composition-based stats.
Identities = 14/40 (35%), Positives = 21/40 (52%)
Query: 23 GDTKFTILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
G + + RY+ + IGSG+ G + D A + VAIK
Sbjct: 1 GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK 40
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase Mst4 In Complex With An Quinazolin
Length = 301
Score = 26.2 bits (56), Expect = 4.7, Method: Composition-based stats.
Identities = 14/30 (46%), Positives = 17/30 (56%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIK 62
+ L+ IG G+ G V D TQQ VAIK
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIK 54
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 26.2 bits (56), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 16/63 (25%), Positives = 34/63 (53%), Gaps = 1/63 (1%)
Query: 30 LKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 89
++ + ++ +G GA G V A + T++ VA+K + + V + +E + ++NH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINAMLNH 64
Query: 90 KNV 92
+NV
Sbjct: 65 ENV 67
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein
Kinase 32a (Yank1)
Length = 384
Score = 25.8 bits (55), Expect = 5.7, Method: Composition-based stats.
Identities = 13/58 (22%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 33 YQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNH 89
++ L+ IG G+ G VC T++ A+K +++ + ++E ++M+ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 25.8 bits (55), Expect = 5.8, Method: Composition-based stats.
Identities = 18/57 (31%), Positives = 27/57 (47%), Gaps = 7/57 (12%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA---YREFKLMKLVNHKNV 92
+G GA V T AIK F N++ + REF+++K +NHKN+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKV----FNNISFLRPVDVQMREFEVLKKLNHKNI 69
>pdb|3NEV|A Chain A, Crystal Structure Of Yage, A Prophage Protein From E. Coli
K12 In Complex With Kdgal
pdb|3NEV|B Chain B, Crystal Structure Of Yage, A Prophage Protein From E. Coli
K12 In Complex With Kdgal
pdb|3NEV|C Chain C, Crystal Structure Of Yage, A Prophage Protein From E. Coli
K12 In Complex With Kdgal
pdb|3NEV|D Chain D, Crystal Structure Of Yage, A Prophage Protein From E. Coli
K12 In Complex With Kdgal
Length = 298
Score = 25.4 bits (54), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQN--LKPIGSGAQGIVCAAYDTATQQNVAIKKLSR 66
++ L +M HTV+ FT+L Y + + G G + A+ + A Q +V + K R
Sbjct: 169 VAHLRSMIHTVKGAHPHFTVLCGYDDHLFNTLLLGGDGAISASGNFAPQVSVNLLKAWR 227
>pdb|3N2X|A Chain A, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12 In Complex With Pyruvate
pdb|3N2X|B Chain B, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12 In Complex With Pyruvate
pdb|3N2X|C Chain C, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12 In Complex With Pyruvate
pdb|3N2X|D Chain D, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12 In Complex With Pyruvate
Length = 298
Score = 25.4 bits (54), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQN--LKPIGSGAQGIVCAAYDTATQQNVAIKKLSR 66
++ L +M HTV+ FT+L Y + + G G + A+ + A Q +V + K R
Sbjct: 169 VAHLRSMIHTVKGAHPHFTVLCGYDDHLFNTLLLGGDGAISASGNFAPQVSVNLLKAWR 227
>pdb|2V8Z|A Chain A, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12
pdb|2V8Z|B Chain B, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12
pdb|2V8Z|C Chain C, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12
pdb|2V8Z|D Chain D, Crystal Structure Of Yage, A Prophage Protein Belonging To
The Dihydrodipicolinic Acid Synthase Family From E. Coli
K12
Length = 343
Score = 25.4 bits (54), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 10 MSRLSTMFHTVEVGDTKFTILKRYQN--LKPIGSGAQGIVCAAYDTATQQNVAIKKLSR 66
++ L +M HTV+ FT+L Y + + G G + A+ + A Q +V + K R
Sbjct: 198 VAHLRSMIHTVKGAHPHFTVLCGYDDHLFNTLLLGGDGAISASGNFAPQVSVNLLKAWR 256
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 25.4 bits (54), Expect = 7.7, Method: Composition-based stats.
Identities = 15/65 (23%), Positives = 29/65 (44%)
Query: 28 TILKRYQNLKPIGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 87
++ YQ + IG GA +V T A K ++ + ++ RE ++ +L+
Sbjct: 1 SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 88 NHKNV 92
H N+
Sbjct: 61 KHSNI 65
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated
Human Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated
Human Tbk1 Kinase- Uld Domain
Length = 396
Score = 25.0 bits (53), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 27/57 (47%), Gaps = 7/57 (12%)
Query: 39 IGSGAQGIVCAAYDTATQQNVAIKKLSRPFQNVTHAKRA---YREFKLMKLVNHKNV 92
+G GA V T AIK F N++ + REF+++K +NHKN+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKV----FNNISFLRPVDVQMREFEVLKKLNHKNI 69
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.131 0.370
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 2,348,292
Number of Sequences: 62578
Number of extensions: 72504
Number of successful extensions: 577
Number of sequences better than 100.0: 325
Number of HSP's better than 100.0 without gapping: 259
Number of HSP's successfully gapped in prelim test: 66
Number of HSP's that attempted gapping in prelim test: 287
Number of HSP's gapped (non-prelim): 325
length of query: 94
length of database: 14,973,337
effective HSP length: 61
effective length of query: 33
effective length of database: 11,156,079
effective search space: 368150607
effective search space used: 368150607
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 45 (21.9 bits)